4Lewis R,Hatzichristow D,Lauman E,et al.Epidemiological and natural history of erectile dysfunction;risk factors including iatrogenic and aging.In:Jardin A,Wagner G,Khoury S,Giuliano F,Padma-Nathan H,Rosen R(eds).Erectile Dysfunction.Plymouth:Plymbridge Distributors Ltd,2000:19-51.
5Kubin M,Wagner G,Fugl-Meyer AR.Epidemiology of erectile dysfunction.Int J Impot Res,2003,15(1):63-71.
6http://zhidao.baidu.com/question/168186958.html.
7Montague D K, Barada J H, Belker A M, et al. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction[J]. J Urol, 1996, 156(6) :2007 - 2011.
8Maneeke R G, Mulhal] J P. Trends in clinical practice: medical treatment of erectile dysfunction [J]. Ann Med, 1999,31 : 388 - 398.
9Moreland R B, Nakane M, Hsieh A, et al. Prospective for pharmacotherapy of male erectile dysfunction[ J]. Curr Opin CPNS Invest Drug, 2000,2(3) :283 - 302.
10Padma-Nathan H, Hellstrom W J G, Kaiser F E, et al. Treat-ment of men with erectile dysfunction with transurethral alprostadil[J]. N Engl J Med, 1997,337(1):1-7.
